Skip to main content
Clinical Trials/NCT03914079
NCT03914079
Suspended
N/A

Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease

AusculSciences Canada Inc.3 sites in 1 country2,000 target enrollmentApril 5, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
AusculSciences Canada Inc.
Enrollment
2000
Locations
3
Primary Endpoint
Number of Participants suspected of having Coronary Artery Disease
Status
Suspended
Last Updated
5 years ago

Overview

Brief Summary

The primary purpose of this multi-center study is to collect and study the acoustic and electrical signals created by the heart during the cardiac cycle as a result of stenosis or plaque associated with coronary artery disease (CAD).

Detailed Description

This research intends to evaluate acoustic and electrical cardiovascular signals in patients with known or suspected CAD and establish the ability of the CAD-det System to accurately and reliably detect them utilizing coronary computed tomography (CCTA) and invasive coronary angiography (ICA) as reference standards. In addition, this study will collect clinical and acoustic data of other cardiac pathologies to better understand their impact on the acoustic signatures associated with CAD.

Registry
clinicaltrials.gov
Start Date
April 5, 2019
End Date
December 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
AusculSciences Canada Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 19 years;
  • Suspected or known CAD;
  • Able and willing to comply with the study procedures;
  • Referred to ICA or CCTA for CAD characterization;
  • Willingness and ability to sign the Informed Consent Form.

Exclusion Criteria

  • Unwillingness or inability to provide informed consent;
  • Age less than 19 years;
  • Skin injury/diseases/lesions that would preclude safe application of the CAD-det device.

Outcomes

Primary Outcomes

Number of Participants suspected of having Coronary Artery Disease

Time Frame: up to 1 Year

Collection of all acoustic cardiac data to allow for the acoustic discrimination of the presence and degree of CAD in diseased and healthy participants.

Secondary Outcomes

  • Estimation of coronary artery stenosis by the CAD-det device.(up to 1 year)
  • Estimation of coronary artery stenosis by CCTA and ICA categorized by sex as:(up to 1 year)

Study Sites (3)

Loading locations...

Similar Trials